Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market

Harvard Bioscience (HBIO) Cash flow

Compare
190 Followers

Harvard Bioscience Cash Flow

HBIO's free cash flow for Q4 2024 was $1.42M. For the 2024 fiscal year, HBIO's free cash flow was decreased by $-12.92M and operating cash flow was $1.73M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 1.44M$ 14.03M$ 1.15M$ 1.26M$ 9.33M
Investing Cash Flow
$ -1.34M$ -1.80M$ -1.59M$ -1.34M$ -1.40M
Financing Cash Flow
$ -131.00K$ -12.13M$ -2.84M$ -252.00K$ -7.97M
End Cash Position
$ 4.11M$ 4.28M$ 4.51M$ 7.82M$ 8.32M
Free Cash Flow
$ -1.20M$ 11.72M$ -438.00K$ -83.00K$ 8.18M
Currency in USD

Harvard Bioscience Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis